SH
Susan Heatley
Also known as: Sue
The University of Adelaide, South Australian Health and Medical Research Institute Limited, Charles Sturt University - Wagga Wagga Campus, The University of Melbourne, Centre for Cancer Biology
Research areas: Medicine · Hematology · Acute Lymphoblastic Leukemia research · Acute Myeloid Leukemia Research · Chronic Lymphocytic Leukemia Research
0000-0001-7497-6477
Employment
-
The University of Adelaide Project Manager2025 - Present
-
University of Adelaide Affiliate Senior Lecturer2013 - Present
-
South Australian Health and Medical Research Institute Limited Postdoctoral Fellow2013 - 2025
-
Centre for Cancer Biology Postdoctoral Scientist2011 - 2013
-
St. Jude Children's Research Hospital Visiting Fellow2010 - 2011
-
Australian Red Cross Blood Service South Australia Medical Scientist1984 - 2011
Education
-
Charles Sturt University - Wagga Wagga Campus Master in Education (Educational Leadership)2011 - 2012
- 2008 - 2011
-
Charles Sturt University - Wagga Wagga Campus Bachelor of Medical Science (Pathology) (Honours)2002 - 2002
Projects & Funding
-
Using Single Cell Sequencing to Elucidate the Clonal Evolution of Acute Lymphoblastic Leukaemia to Prevent Relapse in Children and Improve Outcomes. Channel 7 Children's Research Foundation2024 - 2024
-
Elucidating drug sensitivity and the clonal evolution of Ph-like ALL in adolescents The Kids Cancer Project2016 - 2022
-
Developing a robust screening tool to identify children with Ph-like ALL Channel 7 Children's Research Foundation2015 - 2015
Publications (56)
- Central nervous system involvement in acute lymphoblastic leukemia: pathogenesis and targeted therapy Save
- Activity of STAMP inhibitors in ABL2 rearranged acute lymphoblastic leukemia is dependent on the Abl2 SH3 domain Save
- Diagnostic genomic analysis is prognostic in AYA patients with ALL treated on an MRD-stratified pediatric protocol Save
- Asciminib is a novel inhibitor of ABL1 and ABL2 gene fusions in ALL but requires the ABL SH3 domain for efficacy Save
- Case report: Rare case of donor cell‐derived T‐cell acute lymphoblastic leukaemia in a female patient after receiving an allo‐transplant from her male sibling Save
- Reproducible Bioinformatics Analysis Workflows for Detecting IGH Gene Fusions in B-Cell Acute Lymphoblastic Leukaemia Patients Save
- Case Report: Rare IKZF1 Gene Fusions Identified in Neonate with Congenital KMT2A-Rearranged Acute Lymphoblastic Leukemia Save
- Exploring the oncogenic and therapeutic target potential of the MYB-TYK2 fusion gene in B-cell acute lymphoblastic leukemia Save
- Two novel cases of NUTM1‐rearranged B‐cell acute lymphoblastic leukaemia presenting with high‐risk features Save
- HMGN1 plays a significant role in CRLF2 driven Down Syndrome leukemia and provides a potential therapeutic target in this high-risk cohort Save
- Case Report: Precision Medicine Target Revealed by In Vitro Modeling of Relapsed, Refractory Acute Lymphoblastic Leukemia From a Child With Neurofibromatosis Save
- Identification of a novel GOLGA4–JAK2 fusion gene in B-cell acute lymphoblastic leukaemia Save
- Measurable residual disease analysis in paediatric acute lymphoblastic leukaemia patients with ABL-class fusions Save
- Constitutive JAK/STAT signaling is the primary mechanism of resistance to JAKi in TYK2-rearranged acute lymphoblastic leukemia Save
- Outcomes for Australian children with relapsed/refractory acute lymphoblastic leukaemia treated with blinatumomab Save
- In-vitro modeling of TKI resistance in the high-risk B-cell acute lymphoblastic leukemia fusion gene RANBP2-ABL1 - implications for targeted therapy Save
- TYK2 Activating Alterations in Acute Lymphoblastic Leukemia: Novel Driver Oncogenes with Potential Avenues for Precision Medicine? Save
- High-risk B-cell acute lymphoblastic leukaemia presenting with hypereosinophilia and acquiring a novel PAX5 fusion on relapse Save
- The effect of co-occurring lesions on leukaemogenesis and drug response in T-ALL and ETP-ALL Save
- Activating killer‐cell immunoglobulin‐like receptor haplotype influences clinical outcome following HLA‐matched sibling haematopoietic stem cell transplantation Save